Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticlePractice

Sugar substitutes during pregnancy

Eliza Pope, Gideon Koren and Pina Bozzo
Canadian Family Physician November 2014, 60 (11) 1003-1005;
Eliza Pope
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gideon Koren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pina Bozzo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Question I have a pregnant patient who regularly consumes sugar substitutes and she asked me if continuing their use would affect her pregnancy or child. What should I tell her, and are there certain options that are better for use during pregnancy?

Answer Although more research is required to fully determine the effects of in utero exposure to sugar substitutes, the available data do not suggest adverse effects in pregnancy. However, it is recommended that sugar substitutes be consumed in moderate amounts, adhering to the acceptable daily intake standards set by regulatory agencies.

Sugar substitutes, also referred to as artificial sweeteners, are a great alternative for those looking to replace glucose in their diet. With an increased prevalence of diabetes1 and other diet-related diseases,2 sugar replacements are becoming increasingly popular in items such as food, drinks, oral hygiene products, and pharmaceutical products. Canada’s Food and Drug Regulations specifies how sugar substitutes can be used, as well as the amount allowed, in products, and indicates approval for use of the following nonnutritive artificial sweeteners: acesulfame potassium, aspartame, neotame, polydextrose, Stevia, sucralose, sugar alcohols (known as polyols), saccharin, and thaumatin.3–5

Health Canada states that consumption of sugar substitutes during pregnancy does not pose a health risk but recommends that they be used in moderation so as to not replace nutrients needed for a healthy pregnancy.3 For cases in which pregnant women require sugar substitutes, it is recommended that they consume them according to the acceptable daily intake (ADI). The ADIs have been established by the Food Directorate of Health Canada, and are the same as those set by the Joint Expert Committee of Food Additives of the Food and Agricultural Organization and the World Health Organization.6,7 Table 16–9 summarizes the ADIs for commonly used sugar substitutes and the amount found in commonly consumed products.

View this table:
  • View inline
  • View popup
Table 1.

The ADIs of common sugar substitutes and the amount found in commonly consumed products

A meta-analysis reported that low-calorie beverages approved by the US Food and Drug Administration for consumption during pregnancy did not affect preterm delivery when outcomes for women consuming such beverages were compared with those of women who did not drink sugar-substituted beverages.10

Sugar substitutes

Acesulfame potassium

Acesulfame potassium is a high-intensity sweetener used in food, beverages, oral hygiene products, and a number of pharmaceutical products.11 There is limited research on the safety of acesulfame potassium during pregnancy, but studies have found that the sweetener does cross the placenta.11 An animal study reported that fetuses exposed to acesulfame potassium through the amniotic fluid had an increased preference for sweet solutions and acesulfame potassium solution in adulthood when compared with those in the control group.11 However, these results were reported for concentrations of acesulfame potassium that were substantially greater than typical human exposure.

Aspartame

Aspartame is one of the most common artificial sweeteners used in food and drink. In the small intestine, aspartame breaks down into aspartic acid, phenylalanine, and methanol at levels that are nontoxic to adults, children, and fetuses.12 Several animal studies do not suggest concerns with use of aspartame during pregnancy.13 Human studies found that the breakdown products of aspartame cross the placenta.14 However, a dose of 200 mg/kg of aspartame (4 to 5 times the ADI) did not lead to toxicity, such as methanol poisoning or increase in fetal blood phenylalanine levels to the range associated with mental retardation in offspring.14 Based on available data, consumption of aspartame during pregnancy is not expected to be a concern when staying within the acceptable daily limit.15 It is important to note that women with phenylketonuria should avoid aspartame owing to its breakdown into phenylalanine.3

Neotame

Neotame is a sparsely used chemical derivative of aspartame that is much sweeter.7 Thus far, there are limited data on any potential effects of neotame consumption during pregnancy.

Saccharin

Until recently, saccharin was banned as a sweetener in Canada.4,5 The compound crosses the human placenta at term.16 In a study conducted in rhesus monkeys, fetal elimination of saccharin was much slower than on the maternal side, suggesting that repeated ingestion of saccharin by the mother could lead to a considerable accumulation of the substance in the fetus.17 However, animal data that report exposure with doses 100 to 400 times the human ADI do not suggest a risk of malformations.18 A case-control study reported no increased risk of spontaneous abortions in women who consumed saccharin.19

Stevia

Stevia was approved by Health Canada as a food additive in 2012.4 It is becoming increasingly popular as a natural alternative to artificial sweeteners. The compound originates from the leaves of the Stevia rebaudiana plant, and is used as a noncaloric sweetener.4 In animal studies, Stevia did not increase toxicity in rat embryos, nor did it affect fertility or pregnancy outcomes.20 However, there are no data on the outcomes of use of Stevia during human pregnancies.

Sucralose

Sucralose is another common artificial sweetener. Animal studies report no increased risk of malformations or other adverse fetal effects with exposure to high-dose levels of sucralose during pregnancy.21

Polyols and polydextrose

Polyols are compounds that occur naturally but they are manufactured for use commercially.22 Canada’s Food and Drug Regulations indicate approval for the use of the following sugar alcohols: “hydrogenated starch hydrolysates, isomalt, lactitol, maltitol, maltitol syrup, mannitol, sorbitol, sorbitol syrup, xylitol and erythritol.”22 Limited evidence exists on the effects of polyols during pregnancy. However, owing to the presence of polyols in both maternal and fetal samples from normal pregnancy,23 it is likely that these compounds are safe when consumed in moderation.

Polydextrose is another compound that is approved as a food additive. Unlike polyols, polydextrose supplements texture without adding sweetness to foods.22 It is a synthetic indigestible glucose polymer and is classified as a dietary fibre; therefore, it is not expected to be a concern.24

Thaumatin

Thaumatin is a sweet protein derived from the Thaumatococcus daniellii plant.7 Although little evidence exists on the effects of thaumatin during pregnancy, the protein is processed in the body similarly to other dietary proteins7 and therefore is not expected to have adverse effects during pregnancy.

Conclusion

While data concerning the use of sugar substitutes during pregnancy are limited, they do not suggest an increased risk of toxicity, adverse pregnancy outcomes, or neonatal issues. It is recommended that they be consumed in moderation and that pregnant women adhere to the ADI levels outlined by regulatory directives.

Notes

MOTHERISK

Motherisk questions are prepared by the Motherisk Team at the Hospital for Sick Children in Toronto, Ont. Ms Pope, currently a student at McMaster University in Hamilton, Ont, was a member of Motherisk at the time of preparing this update. Dr Koren is Director and Ms Bozzo is Assistant Director of the Motherisk Program. Dr Koren is supported by the Research Leadership for Better Pharmacotherapy during Pregnancy and Lactation.

Do you have questions about the effects of drugs, chemicals, radiation, or infections in women who are pregnant or breastfeeding? We invite you to submit them to the Motherisk Program by fax at 416 813-7562; they will be addressed in future Motherisk Updates. Published Motherisk Updates are available on the Canadian Family Physician website (www.cfp.ca) and also on the Motherisk website (www.motherisk.org).

Footnotes

  • This article is eligible for Mainpro-M1 credits. To earn credits, go to www.cfp.ca and click on the Mainpro link.

  • La traduction en français de cet article se trouve à www.cfp.ca dans la table des matières du numéro de novembre 2014 à la page e518.

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    Public Health Agency of Canada [website]. Diabetes in Canada: facts and figures from a public health perspective. Ottawa, ON: Public Health Agency of Canada; 2011. Available from: www.phac-aspc.gc.ca/cd-mc/publications/diabetes-diabete/facts-figures-faits-chiffres-2011/chap1-eng.php#DIA. Accessed 2013 Aug 4.
  2. 2.↵
    Public Health Agency of Canada [website]. Obesity in Canada—snapshot. Ottawa, ON: Public Health Agency of Canada; 2012. Available from: www.phac-aspc.gc.ca/publicat/2009/oc/index-eng.php#mfi. Accessed 2013 Aug 13.
  3. 3.↵
    Health Canada [website]. The safety of sugar substitutes. Ottawa, ON: Health Canada; 2008. Available from: www.hc-sc.gc.ca/hl-vs/iyh-vsv/food-aliment/sugar_sub_sucre-eng.php. Accessed 2013 July 25.
  4. 4.↵
    Health Canada [website]. Sugar substitutes. Ottawa, ON: Health Canada; 2010. Available from: www.hc-sc.gc.ca/fn-an/securit/addit/sweeten-edulcor/index-eng.php. Accessed 2013 Jul 25.
  5. 5.↵
    Health Canada [website]. List of permitted sweeteners (list of permitted food additives). Ottawa, ON: Health Canada; 2014. Available from: www.hc-sc.gc.ca/fn-an/securit/addit/list/9-sweetener-edulcorant-eng.php. Accessed 2014 Oct 1.
  6. 6.↵
    Canadian Diabetes Association [website]. Sugars & sweeteners. Toronto, ON: Canadian Diabetes Association; 2014. Available from: www.diabetes.ca/diabetes-and-you/healthy-living-resources/diet-nutrition/sugar-sweeteners. Accessed 2014 Oct 1.
  7. 7.↵
    World Health Organization [website]. Evaluations of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) list of chemicals in functional class sweetener. Geneva, Switz: World Health Organization; 2010. Available from: http://apps.who.int/food-additives-contaminants-jecfa-database/search.aspx?fc=66#. Accessed 2013 Oct 12.
  8. 8.
    Beverage Institute for Health and Wellness [web-site]. Low- and no-calorie sweeteners. Atlanta, GA: The Coca-Cola Company; 2013. Available from: http://beverageinstitute.org/us/article/understanding-low-and-no-calorie-sweeteners-safety-guidelines-adi-and-estimated-intakes/. Accessed 2013 Aug 13.
  9. 9.↵
    EatRight Ontario [website]. Sweet foods and diabetes—can people with diabetes still eat sugar? Toronto, ON: Dietitians of Canada; 2014. Available from: www.eatrightontario.ca/en/Articles/Diabetes-Prevention/Sweet-foods-and-diabetes-–-can-people-with-diabete.aspx. Accessed 2013 Aug 13.
  10. 10.↵
    1. La Vecchia C
    . Low-calorie sweeteners and the risk of preterm delivery: results from two studies and a meta-analysis. J Fam Plann Reprod Health Care 2013;39(1):12-3.
    OpenUrlFREE Full Text
  11. 11.↵
    1. Zhang GH,
    2. Chen ML,
    3. Liu SS,
    4. Zhan YH,
    5. Quan Y,
    6. Qin YM,
    7. et al
    . Effects of mother’s dietary exposure to acesulfame-K in pregnancy or lactation on the adult offspring’s sweet preference. Chem Senses 2011;36(9):763-70. Epub 2011 Jun 7.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Franz M
    . Is it safe to consume aspartame during pregnancy? A review. Nutrition update. Diabetes Educ 1986;12(2):145-7.
    OpenUrlFREE Full Text
  13. 13.↵
    1. Ranney RE,
    2. Mares SE,
    3. Schroeder RE,
    4. Hutsell TC,
    5. Raczialowski FM
    . The phenylalanine and tyrosine content of maternal and fetal body fluids from rabbits fed aspartame. Toxicol Appl Pharmacol 1975;32(2):339-46.
    OpenUrlPubMed
  14. 14.↵
    1. Sturtevant FM
    . Use of aspartame in pregnancy. Int J Fertil 1985;30(1):85-7.
    OpenUrlPubMed
  15. 15.↵
    Health Canada [website]. Health Canada comments on the recent study relating to the safety of aspartame. Ottawa, ON: Health Canada; 2006. Available from: www.hc-sc.gc.ca/fn-an/securit/addit/sweeten-edulcor/aspartame_statement-eng.php. Accessed 2013 Jul 25.
  16. 16.↵
    1. Cohen-Addad N,
    2. Chatterjee M,
    3. Bekersky I,
    4. Blumenthal HP
    . In utero-exposure to saccharin: a threat? Cancer Lett 1986;32(2):151-4.
    OpenUrlPubMed
  17. 17.↵
    1. Pitkin RM,
    2. Reynolds WA,
    3. Filer LJ Jr.,
    4. Kling TG
    . Placental transmission and fetal distribution of saccharin. Am J Obstet Gynecol 1971;111(2):280-6.
    OpenUrlPubMed
  18. 18.↵
    1. Dropkin RH,
    2. Salo DF,
    3. Tucci SM,
    4. Kaye GI
    . Effects on mouse embryos of in utero exposure to saccharin: teratogenic and chromosomal effects. Arch Toxicol 1985;56(4):283-7.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Kline J,
    2. Stein ZA,
    3. Susser M,
    4. Warburton D
    . Spontaneous abortion and the use of sugar substitutes (saccharin). Am J Obstet Gynecol 1978;130(6):708-11.
    OpenUrlPubMed
  20. 20.↵
    1. Geuns JM
    . Stevioside. Phytochemistry 2003;64(5):913-21.
    OpenUrlPubMed
  21. 21.↵
    1. Kille JW,
    2. Tesh JM,
    3. McAnulty PA,
    4. Ross FW,
    5. Willoughby CR,
    6. Bailey GP,
    7. et al
    . Sucralose: assessment of teratogenic potential in the rat and the rabbit. Food Chem Toxicol 2000;38(Suppl 2):S43-52.
    OpenUrlPubMed
  22. 22.↵
    Health Canada [website]. Sugar alcohols (polyols) & polydextrose used as sweeteners in foods. Ottawa, ON: Health Canada; 2005. Available from: www.hc-sc.gc.ca/fn-an/securit/addit/sweeten-edulcor/polyols_polydextose_factsheet-polyols_polydextose_fiche-eng.php. Accessed 2013 Jul 30.
  23. 23.↵
    1. Brusati V,
    2. Jozwik M,
    3. Jozwik M,
    4. Teng C,
    5. Paolini C,
    6. Marconi A,
    7. et al
    . Fetal and maternal non-glucose carbohydrates and polyols concentrations in normal human pregnancies at term. Pediatr Res 2005;58(4):700-4.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Raninen K,
    2. Lappi J,
    3. Mykkänen H,
    4. Poutanen K
    . Dietary fiber type reflects physiological functionality: comparison of grain fiber, inulin, and polydextrose. Nutr Rev 2011;69(1):9-21.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 60 (11)
Canadian Family Physician
Vol. 60, Issue 11
1 Nov 2014
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Sugar substitutes during pregnancy
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Sugar substitutes during pregnancy
Eliza Pope, Gideon Koren, Pina Bozzo
Canadian Family Physician Nov 2014, 60 (11) 1003-1005;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Sugar substitutes during pregnancy
Eliza Pope, Gideon Koren, Pina Bozzo
Canadian Family Physician Nov 2014, 60 (11) 1003-1005;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Sugar substitutes
    • Conclusion
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • Les succédanés du sucre durant la grossesse
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Managing type 2 diabetes in primary care during COVID-19
  • Effectiveness of dermoscopy in skin cancer diagnosis
  • Spontaneous pneumothorax in children
Show more Practice

Motherisk Update

  • Hepatitis A infection during pregnancy
  • Fluconazole use during breastfeeding
  • Is it safe to breastfeed while taking methylphenidate?
Show more Motherisk Update

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2021 by The College of Family Physicians of Canada

Powered by HighWire